Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Clenbuterol hydrochloride by CuraSen Therapeutics for Parkinson's Disease: Likelihood of Approval
Clenbuterol hydrochloride is under clinical development by CuraSen Therapeutics and currently in Phase II for Parkinson's Disease. According to GlobalData,...
Data Insights
Clenbuterol hydrochloride by CuraSen Therapeutics for Parkinson's Disease: Likelihood of Approval
Clenbuterol hydrochloride is under clinical development by CuraSen Therapeutics and currently in Phase II for Parkinson's Disease. According to GlobalData,...